CDKN2A and central nervous system cancer: In our longitudinal analysis of three paired initial and recurrent or metastatic high-grade gliomas, the key genetic drivers (e.g., NF1, CDKN2A, ATRX) were shared truncal events while only chromosomal copy number aberrations were private to initial or recurrent/metastatic tumors.